Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023. In this video, Dr. Tara discusses: - (0:34) Impacts of Ferring"s FDA approval on Microba - (5:30) Drivers behind Microba"s increase in revenue - (7:12) What 2023 looks like for Monash IVF - (8:39) Monash IVF"s rating - (11:45) Monash IVF"s impact from legal action Note: This interview was filmed on 7 February 2023.